http://www.legislation.gov.uk/uksi/2026/607/introduction/madeThe Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026enKing's Printer of Acts of Parliament2026-06-16RETAINED EU LAW REFORMDANGEROUS DRUGS These Regulations are made in exercise of the powers in sections 14(2), (3), (4)(a), (b), (c) and (e) and (7) and 20(1)(a) of the Retained EU Law (Revocation and Reform) Act 2023 (c. 28) (“the 2023 Act”). These Regulations revoke, replace and make alternative provision in secondary assimilated law which establish the processes and rules governing the control and trade in drug precursor chemicals in Great Britain, and trade between Great Britain, Northern Ireland and third countries. The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 2026 No. 607 Made 8th June 2026 Coming into force 29th June 2026 The Secretary of State makes these Regulations in exercise of the powers conferred by sections 14(2), (3), (4)(a), (b), (c) and (e) and (7) and 20(1)(a) of the Retained EU Law (Revocation and Reform) Act 2023(“the 2023 Act”). The Secretary of State is a relevant national authority for the purposes of section 14(2) and (3) of the 2023 Act. In accordance with paragraph 5(1) of Schedule 5 to the 2023 Act, a draft of this instrument has been laid before Parliament and approved by a resolution of each House of Parliament. 2023 c. 28. The term “relevant national authority” is defined in section 21(1) of the Retained EU Law (Revocation and Reform) Act 2023.